Molecular biology brings to neuroscience the ability to clone receptors and design drugs to fit them. How quickly will ligand screens translate into products and profits?
Cite this article
Knight, P. Neurobiotech: Issues, No Answers. Nat Biotechnol7, 1009–1012 (1989). https://doi.org/10.1038/nbt1089-1009
